Nitta K, Wajima R, Tachibana G, Inoue S, Ohigashi T, Kurashima H, Sugiyama K. Predicting Lifetime Transition Risk Of Severe Visual Field Defect Using The Monte Carlo Simulation In Japanese Primary Open-Angle Glaucoma Patients. WGC2017 Helsinki, Finland, June 28- July 1, 2017.
Okumura H, Inoue S, Naidoo S, Holmstrom S, Akaza H. Cost-effectiveness analysis of enzalutamide for patients with chemotherapy-naïve metastatic castration-resistant prostate cancer in Japan. ISPOR 22nd Annual International Meeting, Boston, Massachusetts, USA, May 20–24, 2017.
Nitta K, Inoue S, Fujiwara R, Daito T, Sugiyama K. Study on the forecast formula of suffering severe vision disability withbroadly defined primary open angle Glaucoma. The 27th Meeting of Japan Glaucoma Society. 17-19 September 2016.
Okubo Y, Tsuruta D, Tang A, Inoue S, Itakura H, Hanada T, Otsuki M. Research about gap of treatment goals between doctors’ groups and psoriasis patients’ groups in Japan. The 115th Annual Meeting of the Japanese Dermatological Association. June 3-5, 2016.
Yamabe K, Inoue S, Kuwabara H, Kobayashi M. Cost-effectiveness analysis for treatment of parkinson’s disease: A systematic review. ISPOR 19th Annual European Congress, Vienna, Austria. 29 October-2 November 2016.
Uda A, Hiroi S, Inoue S, Kuwabara H, Yamabe K, Otake K. Study on Patient-Reported Outcomes in Inflammatory Bowel Disease Treatment: A Systematic Review of the Literature. HTAi2016, Tokyo, Japan. 10-14 May, 2016.
Nitta K, Wajima R, Tachibana G, Inoue S, Fujiwara R, Sugiyama K. Analysis of Risk Factors for Visual Field Progression in Open Angle Glaucoma. ARVO2016, Seattle, WA, USA. 1-5 May, 2016.
Kobayashi M. The Whole picture of cost-efectiveness evaluation in japan. 3th seminar of the center of pharmacoeconomics and QOL research at Niigata University of health and welfare. Niigata University of health and welfare, Niigata, Japan. 5th Mar, 2016. (in Japanese).
Yuasa A, Ii Y, Yamamoto Y, Kitazaki S, Murata T, Saito K, Fujimoto Y. Outcome Research To Investigate The Actual Status of MRSA Infection and Usage of ANTI-MRSA Drugs in Real Clinical Settings in Japan : A Retrospective Database Study. ISPOR 18th Annual European Congress, Milan, Italy. 7-11 November, 2015.
Ikeda S, Murata T, Kobayashi M. Role of cost-effectiveness analysis in pricing process of new drug in Japan. ISPOR 18th Annual European Congress, Milan, Italy. 7-11 November, 2015.